Brean Murray Downgrades CardioNet (BEAT) to Hold; Lowers Estimates
Brean Murray downgrades CardioNet (Nasdaq: BEAT) from Buy to Hold.
Brean analyst says, "While we are long-term believers in telemetry-based monitoring platforms, we are moving to the sidelines based on lack of visibility or positive catalysts for the stock in the near-term...We are reducing FY09 and FY10 estimates to $143 million and $128 million from $149 million and $133 million...Our GAAP EPS for FY09 and FY10 are reduced to ($0.44) and ($0.85), respectively."
To see more analyst ratings on BEAT Click Here.
CardioNet, Inc. provides ambulatory, continuous, real-time outpatient management solutions for monitoring relevant and timely clinical information regarding an individual's health in the United States.
Related Categories
DowngradesStocks Mentioned
Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
